Kallyope Inc..'s early discovery research into the gut-brain axis is beginning to mature, with the company's focus now on translating that research into the development of potential drug candidates.
Kallyope's Discovery Research Into The Gut-Brain Axis Advances
Emerging Company Profile: Kallyope is translating early research of the gut-brain axis into small molecules that could have potential in a wide range of therapy areas. The company closed an $87m Series B funding round last year.
